ADORA2A and diabetes mellitus: Diabetes significantly increased by 3.4-fold the protein levels of TSPO in the retina of diabetic animals (p < 0.01) when compared with the control condition (saline-injected retinas from non-diabetic animals) (Fig. 2D), and this effect was abolished by the A2AR antagonist.